Lataa...
Epigenetics in Brain Tumors: HDACs Take Center Stage
Primary tumors of the brain account for 2 % of all cancers with malignant gliomas taking the lion’s share at 70 %. Malignant gliomas (high grade gliomas WHO° III and °IV) belong to one of the most threatening tumor entities known for their disappointingly short median survival time of just 14 months...
Tallennettuna:
| Julkaisussa: | Curr Neuropharmacol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Bentham Science Publishers
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4787285/ https://ncbi.nlm.nih.gov/pubmed/26521944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X13666151030162457 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|